Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 21356068)

1.

Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine.

Verbeken M, Suleman S, Baert B, Vangheluwe E, Van Dorpe S, Burvenich C, Duchateau L, Jansen FH, De Spiegeleer B.

Malar J. 2011 Feb 28;10:51. doi: 10.1186/1475-2875-10-51.

2.

A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products.

Suleman S, Vandercruyssen K, Wynendaele E, D'Hondt M, Bracke N, Duchateau L, Burvenich C, Peremans K, De Spiegeleer B.

Malar J. 2013 Apr 30;12:145. doi: 10.1186/1475-2875-12-145.

3.

Stability profiling of anti-malarial drug piperaquine phosphate and impurities by HPLC-UV, TOF-MS, ESI-MS and NMR.

Yan F, Liu J, Zeng X, Zhang Y, Hang T.

Malar J. 2014 Oct 13;13:401. doi: 10.1186/1475-2875-13-401.

4.
5.

Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection.

César Ida C, Andrade Nogueira FH, Antônio Pianetti G.

J Pharm Biomed Anal. 2008 Nov 4;48(3):951-4. doi: 10.1016/j.jpba.2008.05.022. Epub 2008 May 28.

PMID:
18602241
6.

Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.

Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L; Pyronaridine-artesunate Study Team.

Lancet. 2010 Apr 24;375(9724):1457-67. doi: 10.1016/S0140-6736(10)60322-4.

PMID:
20417857
7.
8.

Interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum in vitro.

Starzengruber P, Kollaritsch H, Sirichaisinthop J, Wernsdorfer G, Congpuong K, Wernsdorfer WH.

Wien Klin Wochenschr. 2008;120(19-20 Suppl 4):85-9. doi: 10.1007/s00508-008-1080-8.

PMID:
19066780
9.

A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.

Lalitha Devi M, Chandrasekhar KB.

J Pharm Biomed Anal. 2009 Dec 5;50(5):710-7. doi: 10.1016/j.jpba.2009.05.038. Epub 2009 Jun 6.

PMID:
19632800
10.

Comparison of HPLC, UV spectrophotometry and potentiometric titration methods for the determination of lumefantrine in pharmaceutical products.

da Costa César I, Nogueira FH, Pianetti GA.

J Pharm Biomed Anal. 2008 Sep 10;48(1):223-6. doi: 10.1016/j.jpba.2008.05.006. Epub 2008 May 17.

PMID:
18571353
11.

Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.

Zongo I, Dorsey G, Rouamba N, Tinto H, Dokomajilar C, Guiguemde RT, Rosenthal PJ, Ouedraogo JB.

Lancet. 2007 Feb 10;369(9560):491-8. Erratum in: Lancet. 2007 Mar 10;369(9564):826.

PMID:
17292769
12.

Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.

Kredo T, Mauff K, Van der Walt JS, Wiesner L, Maartens G, Cohen K, Smith P, Barnes KI.

Antimicrob Agents Chemother. 2011 Dec;55(12):5616-23. doi: 10.1128/AAC.05265-11. Epub 2011 Sep 26.

13.

Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.

Omari AA, Gamble C, Garner P.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005564. Review.

PMID:
16235412
14.

Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of artemether and lumefantrine in human plasma: application for a pharmacokinetic study.

César IC, Ribeiro JA, Teixeira Lde S, Bellorio KB, de Abreu FC, Moreira JM, Chellini PR, Pianetti GA.

J Pharm Biomed Anal. 2011 Jan 5;54(1):114-20. doi: 10.1016/j.jpba.2010.07.027. Epub 2010 Aug 17.

PMID:
20719459
16.

Artemether-lumefantrine for treating uncomplicated falciparum malaria.

Omari AA, Preston C, Garner P.

Cochrane Database Syst Rev. 2002;(3):CD003125. Review. Update in: Cochrane Database Syst Rev. 2003;(2):CD003125.

PMID:
12137676
17.

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.

Arinaitwe E, Sandison TG, Wanzira H, Kakuru A, Homsy J, Kalamya J, Kamya MR, Vora N, Greenhouse B, Rosenthal PJ, Tappero J, Dorsey G.

Clin Infect Dis. 2009 Dec 1;49(11):1629-37. doi: 10.1086/647946.

18.

Influence of coadministration of artemether and lumefantrine on selected plasma biochemical and erythrocyte oxidative stress indices in female Wistar rats.

Abolaji AO, Eteng MU, Omonua O, Adenrele Y.

Hum Exp Toxicol. 2013 Feb;32(2):206-15. doi: 10.1177/0960327112464666. Epub 2012 Nov 15.

PMID:
23155202
19.

Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria.

Omari AA, Gamble C, Garner P.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005965. Review.

PMID:
16625646
20.

Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects.

Abdulla S, Amuri B, Kabanywanyi AM, Ubben D, Reynolds C, Pascoe S, Fitoussi S, Yeh CM, Nuortti M, Séchaud R, Kaiser G, Lefèvre G.

Malar J. 2010 Sep 3;9:253. doi: 10.1186/1475-2875-9-253.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk